Measurement and Reversal of Prophylactic and Therapeutic Peak Levels of Rivaroxaban

Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting

(2013) Jerrold H. Levy et al.   ANESTHESIOLOGY

Reversal of Oral Anticoagulation

(2013) Jonathan L. Thigpen et al.   PHARMACOTHERAPY

Breakthroughs in Anticoagulation: Advent of the Oral Direct Factor Xa Inhibitors

(2012) John G.T. Augoustides   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Novel Oral Anticoagulants

(2011) Donat R. Spahn et al.   ANESTHESIOLOGY

Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model

(2011) Anne Godier et al.   ANESTHESIOLOGY

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

New oral anticoagulants

(2011) Taki Galanis et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time

(2011) Christian Hesse et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

(2011) Genevieve Contant et al.   THROMBOSIS AND HAEMOSTASIS

Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients

(2010) H. AGERSØ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

(2010) Edelgard Lindhoff-Last et al.   THERAPEUTIC DRUG MONITORING

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

(2010) Jean-Luc Martinoli et al.   THROMBOSIS AND HAEMOSTASIS

Neue orale Antikoagulanzien

(2009) B. Heindl et al.   ANAESTHESIST

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation

(2007) Kenichi A. Tanaka et al.   THROMBOSIS RESEARCH